Skip to main content
Premium Trial:

Request an Annual Quote

Personalis Taps Berry Genomics to Facilitate Expansion in China

NEW YORK – Personalis said on Wednesday that it is partnering with Berry Genomics to facilitate its expansion into China.

Personalis said that it plans to form a wholly owned subsidiary in Shanghai, including a laboratory for local customers to use its ImmunoID NeXT platform, a commercial team to support local customers, and general and administrative functions.

Under the terms of the agreement, Berry Genomics will provide Personalis with certain services and local support.

"Having achieved a high degree of scale in our Menlo Park, California operation, we are poised to expand globally, and entering into a partnership with a company that has the track record and capabilities of Berry Genomics will help us accelerate the ramp-up of our operation," Personalis CEO John West said in a statement. "Both companies have benefited from experience founded in the origin of next-generation sequencing, and together we will take it even further."

The ImmunoID NeXT platform leverages deep sequencing to enable researchers studying immune- and precision oncology to comprehensively analyze a tumor and its microenvironment from a single sample across the entire approximately 20,000-gene footprint.

Earlier this year Personalis launched a dedicated pharmaceutical services program to expand beyond its translational and clinical cancer research customer base.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.